ATLyphe is a Swiss biotechnology spin-off from ETH Zurich and the University of Zurich founded in 2023 and based in Zürich. The company develops antibody-based solutions engaging…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see ATLyphe →Already a subscriber? Sign in
Xcout Intel tracks ATLyphe continuously — this profile deepens as new filings, funding, people and hiring data arrive.